Humacyte Submits Supplemental Biologics License Application to FDA for the Acellular Tissue Engineered Vessel in Dialysis Access
–sBLA submission seeks to add arteriovenous access for hemodialysis as second approved indication for the ATEV.
North Carolina – Regional Life Sciences Roundup -October 23th, 2026 Each week, our Regional Roundup delivers the most important and timely life sciences news from around the region. From groundbreaking research to fundraising, new development projects, and who’s hiring — we bring you the top stories that matter most. Stay informed with a curated selection […]
Read More →–sBLA submission seeks to add arteriovenous access for hemodialysis as second approved indication for the ATEV.
DURHAM, N.C.–(BUSINESS WIRE)–Nov. 20, 2026– Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies…
CARMEL, Ind. (November 17, 2026) — SEPRO ScientificTM today announced its acquisition of Bend Genetics, a Sacramento-based aquatic diagnostics laboratory.
Inclusion in the Russell 2000®, Russell 3000®, and Russell Microcap® follows the Company's August 2026 initial public offering and takes effect with FTSE Russell's December 2026 reconstitution
WINSTON-SALEM, N.C., Nov. 18, 2026 (GLOBE NEWSWIRE) — ProKidney Corp. (Nasdaq: PROK) (“ProKidney” or the “Company”), a leading late clinical-stage cell therapy company focused on chronic kidney disease (CKD), today…
Sharma Oral Surgery , a Charlotte, North Carolina-based oral and maxillofacial surgery practice, has transferred ownership to Dr. Rodrigo Sarmento, DMD, MD , following the retirement of its founder, Dr.
BioHealth Capital Region – Regional Life Sciences Roundup – November 16, 2026 The BioHealth Capital Region built infrastructure this week. The pattern ran across facility openings, education programs, research networks and leadership appointments. Each filled in a different part of the region’s research and education infrastructure. ATCC opened its Centennial Biomanufacturing Center in Manassas, expanding […]
Everett Cunningham, veteran diagnostics and commercial leader, appointed Chief Executive Officer to lead next phase of growth
Alexion, AstraZeneca Rare Disease’s Klygefa (gefurulimab) has been approved in the US for the treatment of generalised myasthenia gravis (gMG) in adult patients who are anti-acetylcholine receptor (AChR) antibody…